Discovering protective T-cell responses by interrogating naturally processed antigenic determinants
Pavlo Gilchuk(AstraZeneca (Japan)), Charles T. Spencer(The University of Texas at El Paso), Søren Buus(University of Copenhagen), Alessandro Sette(La Jolla Institute for Immunology), Stephanie B. Conant(Vanderbilt University), John C. Williams(Columbia University), Sine Reker Hadrup(Herlev Hospital), Sebastian Joyce(Walther Cancer Foundation), James E. Crowe(Vanderbilt University Medical Center), William H. Hildebrand(University of Oklahoma Health Sciences Center), Mu Zheng, John J. Erickson(Vanderbilt University), Andrew J. Link(Vanderbilt University), Kathryn Edwards, Hill Timothy, Carla Oseroff(La Jolla Institute for Immunology), Jennifer McAfee, Jennifer J. Gray(Vanderbilt University), Kelli L. Boyd(Vanderbilt University Medical Center), Ton N. Schumacher(Leiden University Medical Center), Jack R. Bennink(National Institutes of Health), Xinann Niu
Unknown
January 1, 2013
Cited by 0
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
|Cell|2020|4k
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
|Science|2016|3.1k
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k